GlassScriptPrepare for your visit
Halie A Guinn
Family · Nashville, TN · NPI 1124003520
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$898.30
in general payments reported to CMS, 2019-2025 · $553 in 2025
The $553 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Janssen Biotech, INC. $231.09
- Stemline Therapeutics INC. $149.83
- Tersera Therapeutics LLC $109.43
- Glaxosmithkline, LLC. $91.17
- Octapharma USA, INC. $57.15
- Pharmacosmos Therapeutics INC. $41.53
Drugs and devices associated with these payments
Darzalex Talvey Tecvayli Orserdu Ojjaara Zoladex Octagam Immune Globulin (Human) Monoferric Frindovyx Erleada Rubraca Quzyttir
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Halie Guinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10914084/halie-a-guinn